Agios Pharmaceuticals, Inc.
DE ˙ DB ˙ US00847X1046
€ 23,40 ↑0.80 (3.54%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:8AP / Agios Pharmaceuticals, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership9,045 shares
Latest Disclosed Value $ 305,992
Prudential Financial Inc reports 88.84% decrease in ownership of 8AP / Agios Pharmaceuticals, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 9,045 shares of Agios Pharmaceuticals, Inc. (DE:8AP) valued at $233,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 81,055 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -88.84% during the quarter. The current value of the position is $211,653 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 9,045 -72,010 -88.84 306 -86.17 0.0004
2026-02-13 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 81,055 -17,184 -17.49 2,206 -44.05 0.0027
2025-11-13 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 98,239 -60,120 -37.96 3,943 -25.14 0.0047
2025-08-12 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 158,359 -45,883 -22.47 5,267 -11.98 0.0068
2025-05-13 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 204,242 99,320 94.66 5,984 73.60 0.0085
2025-02-11 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 104,922 55,400 111.87 3,448 56.68 0.0047
2024-11-14 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 49,522 -58,330 -54.08 2,200 -52.69 0.0031
2024-08-13 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 107,852 -86,280 -44.44 4,651 -18.08 0.0070
2024-05-14 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 194,132 124,600 179.20 5,676 266.67 0.0080
2024-02-13 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 69,532 -120 -0.17 1,548 -10.16 0.0023
2023-11-13 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 69,652 -43,200 -38.28 1,724 -46.07 0.0027
2023-08-11 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 112,852 112,852 3,196 0.0047
2022-11-04 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -55,858 -100.00 0 -100.00
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 55,858 42,200 308.98 1,238 211.84 0.0020
2022-05-13 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,658 2,443 21.78 397 7.59 0.0005
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,215 -8,882 -44.20 369 -60.19 0.0005
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 20,097 -67,353 -77.02 927 -80.77 0.0013
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 87,450 87,450 4,820 0.0066
2020-08-12 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -30,108 -100.00 0 -100.00
2020-05-12 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 30,108 -600 -1.95 1,068 -27.15 0.0024
2020-02-11 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 30,708 30,708 1.99 1,466 37.27 0.0022
2019-02-07 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -2,610 -100.00 0 -100.00
2018-11-07 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 2,610 100 3.98 201 -4.74 0.0003
2018-08-13 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 2,510 2,510 211 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.